Medtech Published on March 4, 2020 Medtech Canada is optimistic about the passage of Bill 37. This bill represents an opportunity to increase the efficiency of public administration and paves the way for future health supply regulations. Read more on News Wire
Business environment Published on February 28, 2020 Greater Montréal is more attractive than ever. In 2019, Montréal International (MI) supported 89 direct foreign investment projects, including 58 business set-ups, which means the establishment of more than one new company per week in the region. The MI team also facilitated the recruitment of more than a thousand international skilled workers, and played a strategic role in the attraction of two international organizations, in addition to creating one from scratch, at the request of the Government of Québec. Read more on News Wire
Medtech Published on February 28, 2020 Imeka, a Sherbrooke-based company, announces a partnership with Medical Image Analyse Center (MIAC) in Switzerland. A new alliance between two key players in imaging technology medical. Read more on IMEKA
R&D Published on February 28, 2020 With the largest number of research centres in the country, Montréal is Canada’s research and education capital, and neuroscience is in the top tier of local expertise. Québec is home to more than 800 neuroscience professionals – with over 240 active in the Montréal area alone – and 39 companies related to neuroscience, positioning the city as an international leader for development and innovation in the field. Read more on City of Montreal - Blog
Biotech Published on February 28, 2020 A doctoral student in biology at the Université de Sherbrooke is working on a technology to fight antibiotic-resistant bacteria as an alternative to the use of conventional antibiotics. This patented technology was the basis for the creation of TATUM Bioscience. Read more on Sherbrooke University (UDES)
Artificial Intelligence Published on February 25, 2020 Canada and the United Kingdom collaborate on responsible artificial intelligence Read more on Canada's Government Official Website
Biotech Pharma Published on February 25, 2020 IMV Inc., a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, reported updated results from DeCidE1, an ongoing Phase 2 study of its lead candidate, DPX-Survivac, in patients with advanced recurrent ovarian cancer. The new results show that DPX-Survivac immunotherapy is active and well-tolerated in patients with advanced ovarian cancer. Read more on IMV Inc.
Biotech Published on February 25, 2020 Bioauxilium Introduces THUNDER™, a New Generation of TR‑FRET Cell Signaling Assay Kits. THUNDER™ assay kits are the first real, cost-effective alternatives to ELISAs and other proprietary TR‑FRET or bead-based assay technologies that will allow researchers worldwide to generate trustworthy data faster. Read more on Business Wire
R&D Published on February 25, 2020 Researchers at the Clinical Research Institute of Montreal (IRCM) say they have obtained authorization from China to test an experimental drug against VIDOC-19. The group, led by Dr. Michel Chrétien, says they believe an existing drug called quercetin could not only cure people with the new coronavirus, but also protect others from the risk of contracting the disease. Read more on La Presse